Genmab - ADR Latest Ownership Pattern - Insider, Institutional, Mutual Fund shareholdings

Genmab - ADR XNAS: GMAB

Strong Performer, Getting Expensive

31.80 1.13 (3.68%)

2.7M

XNAS Volume

XNAS 01 Oct, 2025 3:28 PM (EDT)

Acquisition

Genmab to acquire Merus N.V. in an $8 billion all-cash deal to expand its oncology pipeline See details